Ryan D Maynard Cara Therapeutics, Inc. (CARA) insider trading activity

CARA Quotes by TradingView

Ryan D Maynard is CHIEF FINANCIAL OFFICER of Cara Therapeutics, Inc.. Currently has a direct ownership of 13,500 shares of CARA, which is worth approximately $5,670. The most recent transaction as insider was on Feb 01, 2024, when has been sold 13,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.5K
0% 3M change
68.5% 12M change
Total Value Held $5,670

Ryan D Maynard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2024
BUY
Grant, award, or other acquisition
-
13,500 Added 50.0%
13,500 Common Stock
Feb 08 2023
SELL
Open market or private sale
$2,908 $0.53 p/Share
5,488 Reduced 40.65%
8,012 Common Stock

Also insider at

IOVA
IOVANCE BIOTHERAPEUTICS, INC. Healthcare
Director
RDM

Ryan D Maynard

CHIEF FINANCIAL OFFICER
Stamford, CT

Track Institutional and Insider Activities on CARA

Follow Cara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CARA shares.

Notify only if

Insider Trading

Get notified when an Cara Therapeutics, Inc. insider buys or sells CARA shares.

Notify only if

News

Receive news related to Cara Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CARA